34.70
-1.60
(-4.41%)
As of January 15 at 11:55:11 AM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
96,842.00
96,842.00
93,984.00
83,348.00
Cost of Revenue
26,384.00
26,384.00
33,387.00
31,486.00
Gross Profit
70,458.00
70,458.00
60,597.00
51,862.00
Operating Expense
45,022.00
45,022.00
36,813.00
35,494.00
Operating Income
25,436.00
25,436.00
23,784.00
16,368.00
Net Non Operating Interest Income Expense
1,186.00
1,186.00
-74.00
-250.00
Pretax Income
27,132.00
27,132.00
24,209.00
16,435.00
Tax Provision
5,590.00
5,590.00
5,467.00
4,296.00
Net Income Common Stockholders
21,542.00
21,542.00
18,742.00
12,139.00
Diluted NI Available to Com Stockholders
21,542.00
21,542.00
18,742.00
12,139.00
Basic EPS
1.25
--
1.10
0.80
Diluted EPS
1.25
--
1.09
0.80
Basic Average Shares
17,233.60
--
17,038.18
15,173.75
Diluted Average Shares
17,233.60
--
17,194.50
15,173.75
Total Expenses
71,406.00
71,406.00
70,200.00
66,980.00
Net Income from Continuing & Discontinued Operation
21,542.00
21,542.00
18,742.00
12,139.00
Normalized Income
21,542.00
21,542.00
18,742.00
12,139.00
Interest Income
1,320.00
1,320.00
132.00
14.00
Interest Expense
134.00
134.00
206.00
264.00
Net Interest Income
1,186.00
1,186.00
-74.00
-250.00
EBIT
27,266.00
27,266.00
24,415.00
16,699.00
EBITDA
39,875.00
39,875.00
40,568.00
34,893.00
Reconciled Cost of Revenue
26,384.00
26,384.00
33,387.00
31,486.00
Reconciled Depreciation
12,609.00
12,609.00
16,153.00
18,194.00
Net Income from Continuing Operation Net Minority Interest
21,542.00
21,542.00
18,742.00
12,139.00
Normalized EBITDA
39,875.00
39,875.00
40,568.00
34,893.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
12/31/2021 - 7/31/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6945.TWO AP Biosciences Inc
52.40
-0.76%
6879.TWO TCI GENE Inc.
52.00
+0.39%
6814.TWO Lukas Biomedical Inc.
27.60
-0.72%
7754.TWO AnnJi
33.80
+0.15%
6709.TWO Advagene Biopharma Co., Ltd.
20.20
-1.70%
6652.TWO Eusol Biotech Co.,Ltd.
7.80
+2.23%
4197.TWO Visgeneer Inc.
9.78
+2.95%
7729.TWO SBI
21.15
+4.70%
6872.TWO NaviFUS Corp.
26.90
-1.47%
6744.TWO Feng Chi Biotech Corp.
19.70
0.00%